Brightworth’s Axonics, Inc. Common Stock AXNX Stock Holding History

Brightworth’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,450	Closed	-$584K	–	99
2020 Q3	$584K	Hold	11,450	–	–	0.06%	57
2020 Q2	$402K	Hold	11,450	–	–	0.06%	63
2020 Q1	$291K	Hold	11,450	–	–	0.05%	69
2019 Q4	$317K	Hold	11,450	–	–	0.06%	79
2019 Q3	$308K	Hold	11,450	–	–	0.06%	72
2019 Q2	$469K	Hold	11,450	–	–	0.1%	60
2019 Q1	$274K	Buy	+11,450	New	+$208K	0.06%	80

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Brightworth's AXNX Position: Q4 2020 in Review

Brightworth sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2020, closing a stake of 11,450 shares — an estimated $584K sold.

Brightworth first reported a position in AXNX in Q1 2019 and held it in 7 quarters. The position peaked at $584K in Q3 2020. 149 funds tracked by Wall St. Rank hold AXNX as of Q4 2020.

Brightworth reported no remaining Axonics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Brightworth sold 11,450 Axonics, Inc. Common Stock shares in Q4 2020, an estimated $584K.
Brightworth first reported a position in Axonics, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
Brightworth's Axonics, Inc. Common Stock position peaked at $584K in Q3 2020.
149 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2020.

Based on Brightworth's 13F filing for Q4 2020, filed 3 Feb 2021.